Quick Answer
IMMUCELL CORP /DE/ reported Diluted EPS of $0.12 per share (loss) for fiscal year 2025.
IMMUCELL CORP /DE/ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.12 | +53.8% |
| 2024 | -$0.26 | +65.3% |
| 2023 | -$0.75 | -134.4% |
| 2022 | -$0.32 | -3100.0% |
| 2021 | -$0.01 | +92.9% |
| 2020 | -$0.14 | +26.3% |
| 2019 | -$0.19 | +54.8% |
| 2018 | -$0.42 | -1300.0% |
| 2017 | -$0.03 | -125.0% |
| 2016 | $0.12 | -68.4% |
| 2015 | $0.38 | +733.3% |
| 2014 | -$0.06 | -250.0% |
| 2013 | $0.04 | +33.3% |
| 2012 | $0.03 | +121.4% |
| 2011 | -$0.14 | -7.7% |
| 2010 | -$0.13 | -85.7% |
| 2009 | -$0.07 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.02 | +77.8% | -133.3% |
| June 30, 2025 | $0.06 | +130.0% | -62.5% |
| March 31, 2025 | $0.16 | +366.7% | +277.8% |
| September 30, 2024 | -$0.09 | +25.0% | +55.0% |
| June 30, 2024 | -$0.20 | -11.1% | -233.3% |
| March 31, 2024 | -$0.06 | +80.0% | +50.0% |
| September 30, 2023 | -$0.12 | -50.0% | +33.3% |
| June 30, 2023 | -$0.18 | -100.0% | +40.0% |
- IMMUCELL CORP /DE/ showed an increase of +53.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, IMMUCELL CORP /DE/’s diluted eps has declined by 71.4% (from $0.07 per share (loss) to $0.12 per share (loss)).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: